Targeting of Carbon Ion-Induced G2 Checkpoint Activation in Lung Cancer Cells Using Wee-1 Inhibitor MK-1775

Area of Science:

• Oncology
• Radiation Biology
• Molecular Biology

Background:

• The Wee-1 inhibitor MK-1775 sensitizes non-small cell lung cancer (NSCLC) cells to photon radiation by blocking G2 arrest.
• The radiosensitizing effects of MK-1775 combined with carbon (C)-ion radiation are not well understood.

Purpose of the Study:

• To investigate the efficacy of combining C-ion radiation with MK-1775 for killing NSCLC cells.
• To explore the mechanisms of MK-1775-mediated radiosensitization with C-ion and X-ray exposure.

Main Methods:

• Human NSCLC H1299 cells were exposed to X rays or C ions in the presence of MK-1775.
• Cell cycle progression, radiosensitivity, H2AX phosphorylation, and mitotic catastrophe were analyzed.
• Western blotting and flow cytometry were used to assess molecular changes.

Main Results:

• C-ion radiation induced a greater G2 checkpoint arrest than X-ray radiation.
• MK-1775 abrogated radiation-induced G2 arrest, reduced cyclin-dependent kinase 1 (Cdk1) phosphorylation, and restored the mitotic ratio.
• MK-1775 increased sensitivity to both C-ion and X-ray radiation, irrespective of TP53 status.
• MK-1775 enhanced H2AX phosphorylation and mitotic catastrophe in irradiated cells.

Conclusions:

• The G2 checkpoint inhibitor MK-1775 enhances the radiosensitivity of human NSCLC cells to both C-ion and X-ray radiation.
• MK-1775 shows potential as a sensitizing agent in NSCLC radiotherapy, particularly when combined with C-ion radiation therapy.